ClinicalTrials.gg
CompletedNCT01540383FCET2ECUpdated Apr 30, 2026

Effectiveness of Intensive Aphasia Therapy Under Routine Clinical Conditions

An interventional study of Intensive integrative aphasia therapy and Waiting list control group in Aphasia and Stroke, sponsored by University Hospital Muenster. Completed at 1 site in Germany. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-04-30.

Sponsored by University Hospital Muenster · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
156
Allocation
Randomized
Ages
18 Years to 70 Years
Sex
All
01

Study summary

The purpose of this study is to examine whether 3 weeks of intensive language therapy provided in clinical in- and outpatient settings is effective in improving everyday communication in postacute/chronic post-stroke aphasia, as measured by performance on the Amsterdam Nijmegen Everyday Language Test (ANELT).

Read the detailed description

Aims of the study:

This multicenter randomized placebo-controlled study aims to examine whether integrative intensive (> 10 hours/week for at least 3 weeks) language and communication therapy administered under routine clinical conditions translates into a statistically significant functional improvement of everyday communication in patients with chronic aphasia (i.e., aphasia persisting for 6 or more months after the stroke). A further aim is to examine whether therapy-induced improvements are still maintained over a period of six months. The study's results may lead to more targeted treatment regimens and thus to an enhancement of health-related quality of life in persons with chronic aphasia. The data will further provide evidence-based guidelines of best practice in the rehabilitation of persons with chronic aphasia.

Methods:

Fourteen in- and outpatient rehabilitation centres across Germany participate in the study. Via a digital randomization procedure, patients are allocated to one of two groups: an experimental group, starting as soon as feasible with treatment lasting 3 to 6 weeks, and a waiting list control group, whose therapy begins after a three-week delay. Both groups receive a combination of language systematic and communicative-pragmatic language therapy. Everyday language ability will be examined with a standardized outcome measure, and compared between groups at several points: immediately before as well as immediately after and 6 months after completion of (3-6 weeks) intensive language therapy.

Statistical analyses:

The primary analysis compares the changes in functional communication ability (as indicated by changes of pre- to post-therapy functional communication scores on the primary outcome measure, the ANELT) between the experimental and the waiting list control group in an intention-to-treat (ITT) design. To balance for unequal treatment durations across patient ("naturalistic treatment setting"), the critical pre- to post therapy interval is fixed at three weeks, with the option of extension of therapy (provided it is granted by the sickness fund) and re-test after termination of therapy. The long-term stability of potential treatment gains will be re-evaluated 6 months post therapy.

Further exploratory analyses will examine therapy-induced changes in secondary outcome measures (see below) in the experimental compared to the waiting list control group.

Considering that age, gender, time post stroke onset, aphasia type (fluent, non-fluent), aphasia severity (based on the Aachen Aphasia Test [AAT] profile score), baseline cognitive status, the total hours of therapy provided, type of stroke (cortical strokes with or without subcortical involvement), the amount of therapy-concomitant self-administered language practice (e.g. computer-aided practice), and concurrent physio- and neuropsychological therapies might influence functional outcome, the above factors will be included in a multivariate analysis with variable selection. The amount of outpatient therapy provided after discharge from intensive treatment will be statistically controlled by covariate analyses.

Finally, the investigators expect that therapy effects in the waiting list control group will be comparable to those of the experimental group. Thus, after initiation of therapy in the control group after a three-week delay, outcome data will be collected in analogy to the experimental group, and will serve to replicate potential effects of intensive language therapy under routine clinical conditions.

02

Conditions studied

  • Aphasia
  • Stroke

Keywords

  • Communication
  • Language
  • Treatment
  • Intervention
  • Therapy
  • Efficacy
  • Maintenance
  • Recovery
  • Outcome
  • Rehabilitation
  • Treatment Intensity
  • Language Impairment
  • Intensive Language Therapy
  • Functional Communication
  • Functional Improvement
  • Evidence-Based Intervention
  • High-Frequency
03

In context

Aphasia

338 studies on the registry are indexed under Aphasia; 95 are open to participants now.

This study's enrollment of 156 is above the median of 30 across 298 interventional studies indexed under Aphasia.

Browse Aphasia studies →

Lead sponsor

University Hospital Muenster is the lead sponsor of 192 studies on the registry; 20 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • presence of aphasia for at least 6 months after non-hemorrhagic or hemorrhagic cortical or subcortical-cortical stroke
  • native language German
  • participant's comprehension ability needs to be sufficiently high to give
  • participant's language abilities have to allow the administration of the Aachen Aphasia Test (AAT)

Exclusion criteria

Exclusion Criteria:

  • aphasia due to non-vascular etiology
  • no evidence for aphasia (based on AAT subtests 'Token Test' and 'Written Language'
  • severe untreated medical conditions which prohibit participation in intensive language therapy
  • severe vision or hearing problems (uncorrected)
  • participation in another interventional or language therapy study within four weeks before potential enrollment
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
156 participants (actual)

Study arms

  • Experimental
    Intensive aphasia therapy group

    Group starts intensive integrative aphasia therapy within 3 workdays (or as soon as possible) after baseline exam

    Behavioral: Intensive integrative aphasia therapy

  • Other
    Waiting list control group

    Group starts intensive integrative aphasia therapy after a waiting period of at least three weeks

    Behavioral: Waiting list control group

Interventions

  • BehavioralIntensive integrative aphasia therapy

    Intensive language therapy (3 weeks, 5 days/week, \>=2 hours/day) provided in regular clinical setting and consisting of a combination of language systematic and communicative-pragmatic treatment

  • BehavioralWaiting list control group

    Control group starts intensive language therapy after a 3-week waiting period.

06

What researchers measure

Primary outcomes

  1. Changes on the Amsterdam Nijmegen Everyday Language Test (ANELT) - A-scale

    Mean gain in ANELT understandability scores (ANELT A-scale; using the parallel versions ANELT-I and ANELT-II)

    Time frame: Baseline is compared to performance immediately and 6 months post 3 weeks of intensive language therapy. Patients with at least 5 weeks of therapy, performance will also be assessed after therapy completion (on average 6 weeks)

Secondary outcomes

  1. morbidity measure: changes in language-systematic aphasia screening (SAPS)

    Changes from pre- to post therapy of scores on: a (yet unpublished) test to assess language performance in 2 language modalities (perception, production) and 3 language levels (phonological, lexical, morphosyntactic). There are 3 different levels of complexity for each combination of modality and language level. Performance is thus assessed in 18 language domains (2x3x3).

    Time frame: Baseline is compared to performance immediately and 6 months post 3 weeks of intensive language therapy. Patients with at least 5 weeks of therapy, performance will also be assessed after therapy completion (on average 6 weeks)

  2. morbidity measure: changes in communicative-pragmatic screening (KOPS)

    Changes from pre- to post therapy of scores on: an (yet unpublished) test measuring verbal and nonverbal performance in daily life communicative activities of increasing complexity

    Time frame: Baseline is compared to performance immediately and 6 months post 3 weeks of intensive language therapy. Patients with at least 5 weeks of therapy, performance will also be assessed after therapy completion (on average 6 weeks)

  3. morbidity measure: changes in Modified Rankin Scale

    Changes from pre- to post therapy of scores in: the degree of disability or dependence in daily activities

    Time frame: Baseline is compared to performance immediately and 6 months post 3 weeks of intensive language therapy. Patients with at least 5 weeks of therapy, performance will also be assessed after therapy completion (on average 6 weeks)

  4. quality of life measure: changes in German version of the Stroke and Aphasia Quality of Life Scale-39 (SAQOL-39)

    Changes from pre- to post therapy of scores on: Health-related quality of life questionnaire adapted for persons with aphasia

    Time frame: Baseline is compared to performance immediately and 6 months post 3 weeks of intensive language therapy. Patients with at least 5 weeks of therapy, performance will also be assessed after therapy completion (on average 6 weeks)

  5. quality of life measure: changes in Communicative Effectiveness Index (CETI) and the ANELT partner communication questionnaire

    Changes from pre- to post therapy of scores on: ratings of functional communication ability by relatives of persons with aphasia

    Time frame: Baseline is compared to performance 6 months post 3 weeks of intensive language therapy.

  6. morbidity measure: changes in nonverbal cognitive functions

    Changes from pre- to post therapy of scores on: * Nonverbal Learning Test (NVLT) * Trail Making Test * Verbal Fluency Test

    Time frame: Baseline is compared to performance immediately and 6 months post 3 weeks of intensive language therapy. Patients with at least 5 weeks of therapy, performance will also be assessed after therapy completion (on average 6 weeks)

  7. quality of life measure: changes in Visual analog mood scales (VAMS)

    Changes from pre- to post therapy of scores on: assessment of mood visual analog scales (adapted for persons with aphasia)

    Time frame: Baseline is compared to performance immediately and 6 months post 3 weeks of intensive language therapy. Patients with at least 5 weeks of therapy, performance will also be assessed after therapy completion (on average 6 weeks)

  8. changes in Amsterdam-Nijmegen Everyday Language Test (ANELT) - B-scale

    Mean gain in ANELT intelligibility scores (ANELT B-scale; using the parallel versions ANELT-I and ANELT-II)

    Time frame: Baseline is compared to performance immediately and 6 months post 3 weeks of intensive language therapy. Patients with at least 5 weeks of therapy, performance will also be assessed after therapy completion (on average 6 weeks)

  9. changes in Amsterdam-Nijmegen Everyday Language Test (ANELT) - syntactic rating

    Mean gain in syntactic rating scores (syntax rating criteria based on AAT subtest "spontaneous speech") for the ANELT scenarios (using the parallel versions ANELT-I and ANELT-II)

    Time frame: Baseline is compared to performance immediately and 6 months post 3 weeks of intensive language therapy. Patients with at least 5 weeks of therapy, performance will also be assessed after therapy completion (on average 6 weeks)

  10. changes in Amsterdam-Nijmegen Everyday Language Test (ANELT) - nonverbal communication rating

    Mean gain in nonverbal rating scores (criteria based on "Scenario Test") for the ANELT scenarios (using the parallel versions ANELT-I and ANELT-II)

    Time frame: Baseline is compared to performance immediately and 6 months post 3 weeks of intensive language therapy. Patients with at least 5 weeks of therapy, performance will also be assessed after therapy completion (on average 6 weeks)

07

Study locations

1 site
  • University of Muenster
    Münster, North Rhine-Westfalia 48149, Germany
08

References and documents

Publications

  • Breitenstein C, Grewe T, Floel A, Ziegler W, Springer L, Martus P, Huber W, Willmes K, Ringelstein EB, Haeusler KG, Abel S, Glindemann R, Domahs F, Regenbrecht F, Schlenck KJ, Thomas M, Obrig H, de Langen E, Rocker R, Wigbers F, Ruhmkorf C, Hempen I, List J, Baumgaertner A; FCET2EC study group. Intensive speech and language therapy in patients with chronic aphasia after stroke: a randomised, open-label, blinded-endpoint, controlled trial in a health-care setting. Lancet. 2017 Apr 15;389(10078):1528-1538. doi: 10.1016/S0140-6736(17)30067-3. Epub 2017 Mar 1. PubMed 28256356 ↗
  • Baumgaertner A, Grewe T, Ziegler W, Floel A, Springer L, Martus P, Breitenstein C. FCET2EC (From controlled experimental trial to = 2 everyday communication): How effective is intensive integrative therapy for stroke-induced chronic aphasia under routine clinical conditions? A study protocol for a randomized controlled trial. Trials. 2013 Sep 23;14:308. doi: 10.1186/1745-6215-14-308. PubMed 24059983 ↗
09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Apr 2012, a primary completion of Jan 2015 and a completion of Jan 2015. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 6, 2012
First posted
Feb 28, 2012
Start
Apr 2012
Primary completionActual
Jan 2015
CompletionActual
Jan 2015
Last update
Apr 30, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 30, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01540383
Collaborators
Fresenius University of Applied Science, Charite University, Berlin, Germany, Entwicklungsgruppe Klinische Neuropsychologie, Klinikum Bogenhausen, München, Institut für Biometrie und Klinische Epidemiologie, Charité Campus Benjamin Franklin, Berlin, RWTH Aachen University, Bundesverband für die Rehabilitation der Aphasiker e.V., Universitätsklinikum Leipzig, MEDIAN Klinik Grünheide, Brandenburgklinik Berlin-Brandenburg GmbH, St. Mauritius Therapieklinik, Aphasie- und Seniorenzentrum Josef Bergmann Vechta, Behandlungs- und Rehabilitationszentrum für Intensiv-Therapie Lindlar, Wickerklinik Bad Homburg v.d.H., Asklepios Neurological Clinic Falkenstein, Akademische Praxis für Sprachtherapie / Praxis für Rehabilitationswesen Aschaffenburg, Städtisches Klinikum München, Klinikum Bogenhausen, Schoen Clinic Bad Aibling, m&i-Fachklinik Bad Liebenstein, m&i-Fachklinik Enzensberg, m&i-Fachklinik Herzogenaurach, mediclin Klinikum Soltau, Moritz Klinik, Bad Klosterlausnitz, Klinikum Christophsbad, Göppingen, P.A.N.-Zentrum
Responsible party
Sponsor
First posted
Feb 28, 2012
Start date
Apr 2012
Primary completion
Jan 2015
Completion
Jan 2015
Last update
Apr 30, 2026

Study contacts

Annette Baumgaertner, PhD
principal investigator · Hochschule Fresenius University of Applied Science
Caterina Breitenstein, PhD
principal investigator · Neurology, University of Muenster
Agnes Floel, MD
study director · Neurology, Universitätsmedizin Charite, CCM, Berlin
Wolfram Ziegler, PhD
principal investigator · Clinical Neuropsychology Research Group (EKN), Klinikum Bogenhausen, München
Tanja Grewe, PhD
principal investigator · Hochschule Fresenius University of Applied Sciences

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion